Read the Blog
Drugs are a critical part of the prevention and treatment of diseases. While drug treatments are necessary for their positive impact on the quality of patients’ lives, the increasing number of drugs available on the market means a greater potential for drug-drug interactions (DDIs).
Bring your talents and forward-thinking approach to Altasciences and help us develop medicines for those who need them, faster. We have a number of opportunities for you to explore.
Related Press Release
Altasciences is pleased to announce the appointment of Martin Poirier, M.Sc., as Senior Director of Bioanalytical Sciences, based in Altasciences’ preclinical facility in Seattle, WA.
Safety assessments for both small and large molecules
Clinical pharmacology trials from first-in-human to end of Phase II
As part of our full service offering or as standalone solutions
|
||||||||
 |
||||||||
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
| © 2018 Altasciences. All Rights Reserved. |
Our deep expertise and capabilities in a broad range of therapeutic areas encompasses preclinical and early clinical studies for both small molecules and biologics. We can manage your entire program, as well as provide support research services and bioanalytical expertise.
Please see Therapeutic Areas for a fuller discussion of our capabilities and expertise.
Working as a flexible, attentive extension of your team, we offer all you need to move your molecule forward.
